Trials / Completed
CompletedNCT05887791
Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects
Clinical Study to Assess the Effect of a Collagen Hydrolysate on Postprandial Blood Glucose Profile in Prediabetic and Healthy Subjects: Randomized, Double-blind, Placebo-controlled, Cross-over Study With Different Dosages
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 15 (actual)
- Sponsor
- Rousselot BVBA · Industry
- Sex
- All
- Age
- 18 Years – 70 Years
- Healthy volunteers
- Accepted
Summary
To investigate the effect of two different dosages collagen hydrolysate (CH) on postprandial blood glucose and insulin profile in prediabetic and normo-glycaemic subjects.This will be investigated in a cross-over randomized double-blind placebo controlled study design.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DIETARY_SUPPLEMENT | Collagen hydrolysate | Single dose |
| OTHER | Placebo | Single dose |
Timeline
- Start date
- 2023-06-15
- Primary completion
- 2023-12-23
- Completion
- 2024-04-01
- First posted
- 2023-06-05
- Last updated
- 2024-12-17
Locations
1 site across 1 country: Germany
Source: ClinicalTrials.gov record NCT05887791. Inclusion in this directory is not an endorsement.